AHRQ Outcomes Research Should Focus On Diseases, Not Drugs – PhRMA
Executive Summary
Comparative cost-effectiveness research sponsored by the Agency for Healthcare Research & Quality should focus on treatment options rather than comparing drug classes, the Pharmaceutical Research & Manufacturers of America suggested
You may also be interested in...
Rx Comparative Effectiveness Research Funding In Doubt
Prescription drug comparative effectiveness research funding is not in the fiscal year 2005 HHS approps bill reported out of the House Appropriations Committee July 14
Rx Comparative Effectiveness Research Funding In Doubt
Prescription drug comparative effectiveness research funding is not in the fiscal year 2005 HHS approps bill reported out of the House Appropriations Committee July 14
AHRQ Comparative Study Agenda Should Emphasize Lit Reviews – McClellan
The federal government's investment in comparative effectiveness research for drugs should emphasize literature reviews and other alternatives to clinical trials, Centers for Medicare & Medicaid Services Administrator Mark McClellan said